Compare ARK Space & Defense Innovation ETF (ARKX) vs Citius Pharmaceuticals Inc (CTXR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Space & Defense Innovation ETF vs Citius Pharmaceuticals Inc — how do they compare? ARK Space & Defense Innovation ETF trades at $34.39, while Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M). The key difference: ARK Space & Defense Innovation ETF is trading nearer its 52-week high, Citius Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| ARKX | CTXR | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $37.74 | $1.82 |
52-Week Low | $25.46 | $0.48 |
Market Cap | — | $20.01M |
Enterprise Value | — | $16.23M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Space & Defense Innovation ETF
ARKX is an actively managed ETF that invests in companies leading space exploration and defense innovation. It focuses on orbital and sub-orbital aerospace, reusable rockets, and enabling technologies like AI, robotics, and satellite systems.
Read more on ARKX →About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →
